Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AEGR | AMGN | GILD | VRTX | REGN |
| Company | Aegerion Pharma Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.89 | 312.89 | 64.72 | 420.67 | 970.00 |
| High | 2.34 | 314.89 | 66.20 | 423.32 | 979.98 |
| Low | 1.86 | 309.82 | 64.67 | 417.50 | 966.85 |
| Last | 1.97 | 310.15 | 65.96 | 422.78 | 973.80 |
| Change | +0.10 | -2.71 | +1.38 | +3.79 | +5.80 |
| % Change | +5.35% | -0.87% | +2.14% | +0.90% | +0.60% |
| Volume | 2,168,900 | 2,611,745 | 8,732,673 | 1,064,481 | 351,338 |
| 20-Day Average Volume | 335,415 | 2,930,857 | 7,614,349 | 1,107,774 | 491,762 |
| Previous Close | 1.87 | 312.86 | 64.58 | 418.99 | 968.00 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.81 | 281.61 | 65.99 | 401.94 | 919.00 |
| 20-Day Raw Stochastic | 55.95% | 79.89% | 39.52% | 91.71% | 94.10% |
| 20-Day Relative Strength | 51.21% | 65.95% | 39.82% | 62.31% | 61.33% |
| Weighted Alpha | -77.40 | +34.03 | -19.29 | +22.92 | +31.48 |
| Today's Opinion | N/A | 56% Buy | 100% Sell | 56% Buy | 72% Buy |
| Previous Opinion | N/A | 56% Buy | 100% Sell | 56% Buy | 72% Buy |
| Last Month's Opinion | N/A | 40% Sell | 100% Sell | 24% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.23% since 11/22/16 | -0.37% since 05/03/24 | +1.82% since 05/03/24 | +5.41% since 05/03/24 | +1.76% since 05/03/24 |
| Low | 1.79 on 11/23/16 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 |
| High | 2.34 on 11/29/16 | 314.89 on 05/10/24 | 66.20 on 05/10/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 |
| 1-Month | |||||
| %Chg | +7.65% since 10/28/16 | +16.40% since 04/10/24 | -3.17% since 04/10/24 | +6.34% since 04/10/24 | +4.02% since 04/10/24 |
| Low | 1.50 on 11/07/16 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 2.34 on 11/29/16 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 425.65 on 05/08/24 | 979.98 on 05/10/24 |
| 3-Month | |||||
| %Chg | +20.12% since 08/29/16 | +6.54% since 02/09/24 | -10.47% since 02/09/24 | -0.03% since 02/09/24 | +2.14% since 02/09/24 |
| Low | 1.50 on 11/07/16 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 3.35 on 09/29/16 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +8.24% since 05/27/16 | +16.03% since 11/10/23 | -13.12% since 11/10/23 | +13.15% since 11/10/23 | +21.89% since 11/10/23 |
| Low | 1.23 on 06/14/16 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 341.90 on 11/16/23 | 784.96 on 11/15/23 |
| High | 3.35 on 09/29/16 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 55,250 | 167,829,040 | 80,407,072 | 108,121,632 | 106,249,616 |
| Shares Outstanding, K | 29,540 | 536,435 | 1,245,077 | 258,053 | 109,762 |
| Annual Sales | 239,890,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -73,340,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 35,390,000 | 7,447,000,000 | 6,686,000,000 | 2,517,700,000 | 3,145,000,000 |
| Last Quarter Net Income | -26,570,000 | -113,000,000 | -4,170,000,000 | 968,800,000 | 722,000,000 |
| 60-Month Beta | 0.50 | 0.60 | 0.22 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/03/16 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 11/14/16 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 16.11 | 27.81 | 25.75 |